HCC
More Data on Role of Statins in Prevention of HCC and Chronic Liver Disease
A new large retrospective study lends further credence to the evolving theory that statins may help prevent ...
JULY 28, 2025
FDA Approves SIR-Spheres for Unresectable HCC
The FDA approved yttrium-90 (Y-90) resin microspheres (SIR-Spheres, Sirtex Medical) for the treatment of ...
JULY 11, 2025
First-Degree Relatives of MASLD Patients Are at Higher Risk for HCC
Some relatives of people with metabolic dysfunction–associated steatotic liver disease are at higher risk for ...
JANUARY 24, 2024
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular Carcinoma
Results of a retrospective study suggest that the albumin-bilirubin grade might be more useful in classifying ...
NOVEMBER 11, 2023
Researchers Question Value of 30-Day Readmission Metric in HCC
Researchers at several centers across the country are raising doubts about rates of 30-day readmission after liver ...
FEBRUARY 1, 2022
In Meta-Analysis, Multitarget Liquid Biopsy Superior for Early HCC Detection
The results of a recent meta-analysis indicate that multitarget hepatocellular carcinoma liquid biopsy is more ...
JANUARY 31, 2022
BCLC 2022 Update Focuses on Personalizing Treatment
The Barcelona Clinic Liver Cancer (BCLC) updated its recommendations for the prognosis and treatment of liver ...
JANUARY 28, 2022
BMS Withdraws Opdivo Indication for HCC Monotherapy
In consultation with the FDA, Bristol Myers Squibb (BMS) has voluntarily withdrawn from the U.S. market the ...
JULY 26, 2021
For Cirrhotics With HCV, Monitoring for Liver Cancer Warranted Even After Viral Eradication
Although recent advances in direct-acting antiviral therapy have made sustained virologic response (SVR) a reality ...
APRIL 1, 2021
Study Finds ‘Hot Spots’ For Liver Cancer
The investigators said they hope to use these data to implement early detection interventions in these areas, which ...
FEBRUARY 10, 2021
Tecentriq Plus Avastin Approved as First-Line Treatment for Advanced HCC
The FDA approved the use of atezolizumab (Tecentriq, Genentech) in combination with bevacizumab (Avastin, ...
MAY 29, 2020
Nivolumab-Ipilimumab Combo Approved to Treat Previously Treated HCC
The FDA granted accelerated approval for the use of nivolumab plus ipilimumab to treat hepatocellular carcinoma in ...
MARCH 12, 2020